论文信息 - A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors - 字舞流文

A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

A. Oza | Y. Drew | G. Shapiro | P. LoRusso | S. Domchek | H. Burris | J. Balmaña | S. Goble | R. Shapira-Frommer | R. Kristeleit | T. Safra | A. Montes | L. Maloney | Jim J. Xiao | L. Rolfe | J. Isaacson | Lee-may Chen | M. Patel | H. Giordano | Jennifer Borrow